Search SDGR
Schrodinger, Inc.
Nasdaq · CIK 1490978
Last close30.31
Daily change-0.15 (-0.49%)
10 Years gain+5.83%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
SDGR · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 1231
Fundamental
74.0Momentum
100.0Acceleration
100.0Confidence
87.0Annual Revenue7
Quarterly Revenue25
Annual CFO7
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth16.8 / 25
Quality19.6 / 25
Capital Efficiency15.2 / 20
Balance Sheet15.0 / 15
Shareholder Economics4.9 / 10
Forward Indicators2.5 / 5
Signals
Operating leverageOperating margin improved by 50.4474 percentage points.
Warnings
Gross margin compression · MEDIUMGross margin compressed by 4.1421 percentage points.
Key Metrics
Revenue Growth TTM26.73%OK
Revenue CAGR 3Y12.24%OK
Gross Margin51.28%OK
Operating Margin-83.51%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Y-49.92%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y3.71%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $255.87M | $142.61M | -$166.90M | $13.90M | $12.46M | 55.74% | -65.23% | 4.87% | -695.58% | 73.44M |
| 2025 FY Dec 31, 2024 | $207.54M | $132.08M | -$209.30M | -$157.37M | -$164.68M | 63.64% | -100.85% | -79.35% | -213.52% | 72.67M |
| 2025 FY Dec 31, 2023 | $216.67M | $140.69M | -$177.45M | -$136.73M | -$150.14M | 64.94% | -81.9% | -69.29% | -408.82% | 74.99M |
| 2024 FY Dec 31, 2022 | $180.96M | $101.02M | -$146.82M | -$119.68M | -$127.70M | 55.83% | -81.13% | -70.57% | n/a | 71.17M |
| 2023 FY Dec 31, 2021 | $137.93M | $65.62M | -$111.44M | -$70.67M | -$77.84M | 47.57% | -80.8% | -56.43% | n/a | 70.59M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $226.56M | sum latest 4 fiscal quarters Revenue | OK | 0001490978-26-000068, 0001490978-25-000117 |
| Revenue Growth TTM | 26.73% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001490978-26-000068, 0001490978-25-000117 |
| Revenue CAGR 3Y | 12.24% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001490978-26-000010 |
| Revenue CAGR 5Y | 18.81% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001490978-26-000010 |
| Gross Profit CAGR 3Y | 12.18% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001490978-26-000010 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001490978-26-000068, 0001490978-25-000117 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 51.28% | Gross Profit / Revenue | OK | 0001490978-26-000068, 0001490978-25-000117 |
| Operating Margin | -83.51% | Operating Income / Revenue | OK | 0001490978-26-000068, 0001490978-25-000117 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001490978-26-000068 |
| Current Ratio | 2.71x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $2.99 | Revenue / Diluted Shares | OK | 0001490978-26-000068, 0001490978-25-000117 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001490978-26-000010 |